Magic mushroom compound psilocybin tested in major depression trial
Symptom relief
Ongoing
This Phase 3 study tests whether a single 25 mg dose of synthetic psilocybin can reduce depression symptoms in 238 adults with major depressive disorder. Participants receive either psilocybin or a placebo, and their depression severity is measured over 43 days. The trial also lo…
Phase: PHASE3 • Sponsor: Usona Institute • Aim: Symptom relief
Last updated Jun 27, 2026 13:00 UTC